Page 7 - Multiple Sclerosis Ms News Today

For patients with radiologically isolated syndrome (RIS) predictive of multiple sclerosis (MS), teriflunomide reduced the risk of a demyelinating event over a 2-year period in a phase 3 trial.

The incidence and prevalence of myasthenia gravis have increased in the United States, likely due to increased diagnosis and more awareness of the disease over time.

"We are looking at larger sample sizes to improve the accuracy and generalizability of our model, but we can use it now to inform treatment decisions."

Pathology analysis of sentinel lymph nodes during mastectomy for early stage breast cancer is more likely to result in over-aggressive axillary management, suggested a US study.

Data from a phase 3 trial suggest high-dose vitamin D does not prevent relapse in patients with RRMS. However, at least one expert suggests the studys exclusion criteria may have been too broad.

Catching MS cases earlier in children could provide a different treatment trajectory, but early clues are often overlooked.

Contrary to previous research, a new study suggests fertility treatments pose little risk of MS relapse in women who undergo fertility treatments, suggesting it may be time for new clinical guidance.

The chemotherapy duo performed better than expected as a stand-in for bacillus Calmette-Guérin (BCG), which is the gold standard for non–muscle-invasive bladder cancer but is currently in short supply.

With mounting research showing that physical activity affects brain volume, fatigue, and other outcomes, researchers are finding ways to have patients with multiple sclerosis be more active.

A digital tool to measure gait, which has been used in trials of Alzheimers and Parkinsons disease, shows potential in improving measurement of disability among patients with multiple sclerosis.